5-Amino-1MQ
Research draft Fat-related research Best evidence grade C Animal or laboratory research only
Evidence design, not proof of benefit or product approval
Holds on this record
- No supplier batch has been matched to this record. A reviewer must record batch evidence before approval.
- Not marked ready for client selection in the library.
- No human administration guide. Study routes are research descriptions, not instructions.
- Research draft. Not released customer guidance.
The nine headings
Each heading opens a plain summary, then the deeper evidence and the sources behind it.
What it is
5-Amino-1MQ is a small molecule studied as an NNMT enzyme inhibitor. It is not a peptide.
Sources for this tile
- 5-Amino-1MQ: NNMT inhibition in mice (2017 · Published abstract · checked 2026-10-08)
- 5-Amino-1MQ: mouse pharmacology (2024 · Published abstract · checked 2026-10-08)
The history
The checked treatment studies are in mice.
Sources for this tile
- 5-Amino-1MQ: NNMT inhibition in mice (2017 · Published abstract · checked 2026-10-08)
- 5-Amino-1MQ: mouse pharmacology (2024 · Published abstract · checked 2026-10-08)
How it works
Open the pathway notes below. A biological pathway is a possible chain of events in the body. The grade states where it was tested.
Sources for this tile
- 5-Amino-1MQ: NNMT inhibition in mice (2017 · Published abstract · checked 2026-10-08)
- 5-Amino-1MQ: mouse pharmacology (2024 · Published abstract · checked 2026-10-08)
Each proposed mechanism
NNMT enzyme
Mouse and cell work studies inhibition of an enzyme involved in nicotinamide metabolism.
Evidence note: C
Sources
- 5-Amino-1MQ: NNMT inhibition in mice (2017 · Published abstract · checked 2026-10-08)
- 5-Amino-1MQ: mouse pharmacology (2024 · Published abstract · checked 2026-10-08)
Go deeper
NNMT enzyme C
Mouse and cell work studies inhibition of an enzyme involved in nicotinamide metabolism.
Sources
- 5-Amino-1MQ: NNMT inhibition in mice (2017 · Published abstract · checked 2026-10-08)
- 5-Amino-1MQ: mouse pharmacology (2024 · Published abstract · checked 2026-10-08)
What it helps
Open the outcome notes. They show the tested condition and what was measured. A positive marker, a mouse result and a clinical benefit are different things.
Sources for this tile
- 5-Amino-1MQ: NNMT inhibition in mice (2017 · Published abstract · checked 2026-10-08)
- 5-Amino-1MQ: mouse pharmacology (2024 · Published abstract · checked 2026-10-08)
Read this before you read a benefit into it
Laboratory and animal results describe what happened in that model. They are not proven healing in a person. Human studies name their own population, outcome and limits. Both are kept apart here on purpose.
No human study is recorded for this product in this edition.
Animal and laboratory records
5-Amino-1MQ: NNMT inhibition in mice C
| Proof grade | C |
|---|---|
| Design | Mouse treatment experiment |
| People or model | Mice |
| Outcome measured | Body weight and fat |
| Result | Changes in weight, fat and metabolic markers were reported in mice. No human treatment effect follows from that result. |
| Route in the study | Experimental mouse administration |
| Duration | 11 days |
| Personal regimen | Not set. A study regimen is not a personal instruction. |
Source
- 5-Amino-1MQ: NNMT inhibition in mice (2017 · Published abstract · checked 2026-10-08)
5-Amino-1MQ: mouse pharmacology C
| Proof grade | C |
|---|---|
| Design | Mouse pharmacology and treatment |
| People or model | Mice |
| Outcome measured | Metabolic measures |
| Result | The paper studies exposure and metabolic changes in mice. |
| Route in the study | Mouse oral and injection routes |
| Duration | 28 days |
| Personal regimen | Not set. A study regimen is not a personal instruction. |
Source
- 5-Amino-1MQ: mouse pharmacology (2024 · Published abstract · checked 2026-10-08)
Go deeper
Body weight and fat C
C: Tested in Mice. Read the study result in the human or researcher layer. This is a tested outcome, not a promised benefit.
Sources
- 5-Amino-1MQ: NNMT inhibition in mice (2017 · Published abstract · checked 2026-10-08)
Metabolic measures C
C: Tested in Mice. Read the study result in the human or researcher layer. This is a tested outcome, not a promised benefit.
Sources
- 5-Amino-1MQ: mouse pharmacology (2024 · Published abstract · checked 2026-10-08)
The research
Each claim keeps its own source, evidence grade and limits. This is a scoped first research edition. It is not a full review or a personal treatment plan.
Sources for this tile
- 5-Amino-1MQ: NNMT inhibition in mice (2017 · Published abstract · checked 2026-10-08)
- 5-Amino-1MQ: mouse pharmacology (2024 · Published abstract · checked 2026-10-08)
Overall state of the evidence
Status: preclinical-only
No qualifying human intervention study was verified in this pass. Mouse doses cannot be turned into a client plan.
Risk summary
No qualifying human intervention study was verified in this pass. Mouse doses cannot be turned into a client plan.
What is still open
- Supplier identity and batch match have not been verified
- Full-text systematic review and complete interactions are not finished
- Exact chemical identity
- Human safety and interaction data
Checks a reviewer must finish first
- Exact chemical identity
- Human safety and interaction data
How to read the proof grades
- A: Controlled human trial. Note whether randomisation and blinding were confirmed.
- B: Small uncontrolled human study or chart review.
- C: Whole-animal intervention.
- D: Cell or other laboratory study.
- E: User reports. Kept separate and never substituted for a measured outcome.
- ungraded: Identity sources, official labels, notices, reviews and unverified claims are not assigned an efficacy grade.
Go deeper
How to read the proof Open the checked detail
A: controlled human trial. State whether it was blinded and randomized. B: small uncontrolled human study or chart review; a weak clinical comparison is marked with its design limits. C: whole-animal work. D: cells or other lab work. E: user reports.
A grade describes the kind of evidence for one claim. It does not grade every claim about a peptide or approve a product. Labels, history and regulatory reviews are named sources, not efficacy grades.
Sources
- Future Health research method (Christopher’s supplied research method; read in full · checked 2026-10-09)
Open questions Open the checked detail
Supplier identity and batch match have not been verified
Full-text systematic review and complete interactions are not finished
Exact chemical identity
Human safety and interaction data
Research in people
No qualifying product-matched human treatment result was verified in this pass. This is a search limit, not a claim that no study exists.
What people report
No user reports are recorded for this product. The library keeps human studies and user reports in separate places, so nothing is filled in here.
No human study record is attached to this product in this edition.
Why it is for you
This is the shared library. No client has been assessed in this record. This tile will use the person's own words, a named target and checked rule-outs after intake. A catalog entry does not mean it is suitable for someone.
Not filled in for you yet
This heading is personal. It stays blank until your own intake is reviewed and a plan is agreed with you. Nobody else's reasons or results are shown here.
What you would notice
No qualifying human intervention study was verified in this pass. Mouse doses cannot be turned into a client plan.
Sources for this tile
- 5-Amino-1MQ: NNMT inhibition in mice (2017 · Published abstract · checked 2026-10-08)
- 5-Amino-1MQ: mouse pharmacology (2024 · Published abstract · checked 2026-10-08)
Not filled in for you yet
This heading is personal. It stays blank until your own intake is reviewed and a plan is agreed with you. Nobody else's reasons or results are shown here.
How it is taken
Routes in mice are research context only. Human route and regimen remain unfilled. Research routes describe what was studied. They are not a client administration guide.
Sources for this tile
- 5-Amino-1MQ: NNMT inhibition in mice (2017 · Published abstract · checked 2026-10-08)
- 5-Amino-1MQ: mouse pharmacology (2024 · Published abstract · checked 2026-10-08)
Routes seen in the research
No human route is recorded.
Dose and cycle fields in the library
These are blank on purpose. A personal amount, schedule, mixing or storage instruction is only written into an agreed plan after a reviewer checks the exact product.
| dose | Blank |
|---|---|
| unit | Blank |
| frequency | Blank |
| timeOfDay | Blank |
| foodTiming | Blank |
| route | Blank |
| injectionSite | Blank |
| cycleLength | Blank |
| restLength | Blank |
| titration | Blank |
| mixing | Blank |
| storage | Blank |
| expiryAfterMixing | Blank |
Identity
| What it is made of | 5-Amino-1MQ is a small molecule studied as an NNMT enzyme inhibitor. It is not a peptide. |
|---|---|
| Maker | Not recorded |
| Supplier batch matched | No. Not matched to a supplier batch. |
| Catalog sizes | 5mg to 50mg - Inherited reference only; stock and current product sizes unverified |
| Record checked on | 2026-10-08 |
Shared safety note
FDA flags immune reactions and impurities in several compounded peptides. Its notice also reports serious events in IV ipamorelin research, heart-rate and vessel-dilation reactions with CJC-1295, glucose concerns with GHRP-2/6, and serious case reports with melanotan II. Reports do not by themselves establish causation. This concerns proposed compounded products and routes, not every formulation worldwide.
Source
- FDA: compounding safety concerns (FDA · Official safety notice · checked 2026-10-08)